FUISZ TECHNOLOGIES LTD
10-C, 1996-05-10
PHARMACEUTICAL PREPARATIONS
Previous: INVITRO INTERNATIONAL /, 10QSB, 1996-05-10
Next: MEDIMMUNE INC /DE, SC 13G, 1996-05-10



<PAGE>   1
                                            -------------------------------
                                                     OMB APPROVAL            
                                            -------------------------------
                                            OMB NUMBER:  3235-0191         
                                            EXPIRES:  NOVEMBER 30, 1996    
                                            ESTIMATED AVERAGE BURDEN       
                                            HOURS PER RESPONSE ...... 0.20 
                                            -------------------------------
                                      


                                UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549




                                  FORM 10-C

               REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
                         INTERDEALER QUOTATION SYSTEM
                                      
 FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
                     AND RULE 13a-17 OR 15d-17 THEREUNDER
 
                           Fuisz Technologies, Ltd.
- --------------------------------------------------------------------------------
                (Exact name of issuer as specified in charter)



            3810 Concorde Parkway, Suite 100, Chantilly, VA  22021
- --------------------------------------------------------------------------------
                   (Address of principal executive offices)


Issuer's telephone number, including area code   (703) 803-3260
                                               ---------------------------------


                  I. CHANGE IN NUMBER OF SHARES OUTSTANDING

Indicate any change (increase or decrease) of 5% or more in the number of shares
outstanding:

1.  Title of security   Common Stock                    
                      ----------------------------------------------------------

2.  Number of shares outstanding before the change   18,078,191
                                                   -----------------------------

3.  Number of shares outstanding after the change   19,604,741
                                                   -----------------------------

4.  Effective date of change   Underwriting Agreement signed on 4/29/96 -
                             ---------------------------------------------------
Closing Date 5/3/96
- -------------------

5.  Method of change:
    Specify method (such as merger, acquisition, exchange, distribution, stock
    split, reverse split, acquisition of stock for treasury, 
    etc.)   Public Offering
          ----------------------------------------------------------------------

    Give brief description of transaction  The Company issued 1,125,000 shares
                                           -------------------------------------
in a public offering, as well as 401,550 shares upon exercise of options that
- --------------------------------------------------------------------------------
were sold into the offering.
- --------------------------------------------------------------------------------


                         II. CHANGE IN NAME OF ISSUER

1.  Name prior to change
                         -------------------------------------------------------
2.  Name after change
                      ----------------------------------------------------------
3.  Effective date of charter amendment changing name
                                                      --------------------------
4.  Date of shareholder approval of change, if required
                                                        ------------------------


Date   May 9, 1996                              /s/ PATRICK D. SCRIVENS, EVP
     -------------------------------        ------------------------------------
                                                 (Officer's signature & title)





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission